Acetylaconitine | Interleukin Related interleukin-related.com

Product Name :
Acetylaconitine

Search keywords :
Flaconitine

drugId :
null

Target Vo:
Nuclear factor NF-kappa-B complex

Target Vo Short Name :
NF-κB

Moa_Name:
Nuclear factor NF-kappa-B complex inhibitors

First Approval Country :
Mainland China

First Approval Date Filter:
1985

Origin Company_Name :

Active Company_Name :
Shaanxi Xingbang Pharmacevtical Co Ltd

Active Indication_Name:
Pain

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PERK Antibody
PFKFB3 Antibody
PI3 Kinase p85 beta Antibody (YA688): PI3 Kinase p85 beta Antibody (YA688) is a non-conjugated and Mouse origined monoclonal antibody about 82 kDa, targeting to PI3 Kinase p85 beta (8D9). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts